Skip to main
CUTR
CUTR logo

Cutera (CUTR) Stock Forecast & Price Target

Cutera (CUTR) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 50%
Buy 17%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Cutera Inc. has demonstrated robust growth capabilities, as evidenced by a 41% year-over-year increase in AviClear revenue, largely attributable to successful international capital sales following its recent expansion. The company anticipates an additional $10 million in operational cost reductions by 2025 and projects a potential cash tailwind of $25 million through inventory reduction if revenue stabilizes at current levels. Moreover, the successful launch of the xeo+ laser, which has outperformed expectations in securing new accounts, highlights significant growth prospects and potential reinvigoration for Cutera's core business.

Bears say

Cutera Inc. has reduced its FY'24 revenue guidance by $22.5 million at the mid-point, resulting in revised projections of $140 million to $145 million, reflecting a significant year-over-year decline of 31% to 34%. The company's recent quarterly results showcased a revenue shortfall at $34.4 million against a consensus expectation of $161.8 million, indicating underlying challenges in maintaining revenue streams. Additionally, projected cash burn has been elevated to approximately $17.5 million, further raising concerns regarding the company's financial stability and operational efficiency moving forward.

Cutera (CUTR) has been analyzed by 6 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 17% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cutera and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cutera (CUTR) Forecast

Analysts have given Cutera (CUTR) a Buy based on their latest research and market trends.

According to 6 analysts, Cutera (CUTR) has a Buy consensus rating as of Jul 29, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cutera (CUTR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.